|
Solexa
deep sequencing approach Deep Sequencing Approach, supplied by Solexa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/deep+sequencing+approach/10__1016_slash_j__virol__2024__110325-138-21-20 Average 90 stars, based on 1 article reviews
deep sequencing approach - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Oxford Nanopore
deep sequencing approaches based on nanopore Deep Sequencing Approaches Based On Nanopore, supplied by Oxford Nanopore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/nanopore+sequencing/pm38987263-59-7-9 Average 90 stars, based on 1 article reviews
deep sequencing approaches based on nanopore - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
deep sequencing approaches ![]() Deep Sequencing Approaches, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/deep+sequencing+approach/pmc11130118-16-2-7 Average 90 stars, based on 1 article reviews
deep sequencing approaches - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
deep sequencing approach ![]() Deep Sequencing Approach, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/deep+sequencing+approach/pm38578806-148-7-7 Average 90 stars, based on 1 article reviews
deep sequencing approach - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Illumina Inc
16s and its targeted-gene, deep sequencing approach ![]() 16s And Its Targeted Gene, Deep Sequencing Approach, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/16s+rrna+gene+sequencing/pmc10678252-5-6-2 Average 90 stars, based on 1 article reviews
16s and its targeted-gene, deep sequencing approach - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Tajima Shoji Co Ltd
deep-sequencing approaches ![]() Deep Sequencing Approaches, supplied by Tajima Shoji Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/deep-sequencing+approaches/deep+sequencing+approaches/pmc10324950-486-0-24 Average 90 stars, based on 1 article reviews
deep-sequencing approaches - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Journal: Scientific Reports
Article Title: Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations
doi: 10.1038/s41598-024-63054-3
Figure Lengend Snippet: Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore sequencing using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
Article Snippet: In contrast,
Techniques: Sequencing, Nanopore Sequencing
Journal: Scientific Reports
Article Title: Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations
doi: 10.1038/s41598-024-63054-3
Figure Lengend Snippet: Comparisons of nanopore sequencing DR data with archive DR test data obtained by Sanger sequencing. ( A ) Concordance rates (%) of the DR tests between Sanger and nanopore sequencing. The prevalence of detected DR to each drug is displayed with bar graphs. The “Concordant” and “Discordant” columns represent fully matched and inconsistent results between the two sequencing methods. LPV/r: lopinavir boosted with ritonavir, ATV: atazanavir, DRV: darunavir, RTV: ritonavir, ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ABC: abacavir, TDF: tenofovir, TAF: tenofovir alafenamide, ISL: islatravir, EFV: efavirenz, NVP: nevirapine, ETR: etravirine, RPV: rilpivirine, DOR: doravirine, RAL: raltegravir, EVG: elvitegravir, DTG: dolutegravir, CAB: cabotegravir, BIC: bictegravir, LEN: lenacapavir. ( B ) Concordance rates of coreceptor tropism results based on V3 sequences between the two sequencing methods. The concordance rates of CXR4 (X4) tropism are displayed with a bar graph. Putative tropisms were determined by geno2pheno-C_NGS-Sanger ( https://coreceptor.geno2pheno.org/ ). ( C ) The concordance rates of nucleotide sequences in the pol PR-RT , pol IN, gag capsid, matrix and env c2c5 regions are plotted for each sample with medians and interquartile ranges.
Article Snippet: In contrast,
Techniques: Nanopore Sequencing, Sequencing